Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol after infrapopliteal angioplasty for lower limb ischemia
IRCT20190418043306N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in arteriosclerosis obliterans comparing Cilostazol plus Plavix with Plavix control (2 arms). Primary endpoints: Relief of ischemic symptoms, Ischemic ulcer healing and 3 more. Started Mar 2018; status: completed.
02
Drugs
cilostazolclopidogrel
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on IRCT20190418043306N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190418043306N1.